VM3: Regulatory exchange and new/future approaches

By Mel Munro2023-12-05T16:00:00

The coordination group for mutual recognition and decentralised procedures veterinary medicinal products (CMDv), represented by its vice chair Beate Gasser, provided an update on the summary of product characteristics (SPC) harmonisation exercise and G.I.18 variations required to align with the quality review of documents (QRD) product information template v.9. Noting that the SPC harmonisation has now started for the first five products (Catosal, Finadyne, Estrumate, Domesedan and Planate), marketing authorisation holders (MAH) were invited to register interest for the 2024 process before 31 May.

How to read this journal article

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.

1. REGISTER FOR FREE

Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

Create your own library to save your favourite content.

Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.

3. JOIN TOPRA

TOPRA membership

Become a TOPRA member and join our global regulatory affairs community.

Great savings on our events and training.
Be part of our dynamic international community.
Contribute to the profession.
Grow your skills and knowledge.
Take your career to the next level.

Become a member